Concepts (210)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Substance Abuse, Intravenous | 22 | 2020 | 411 | 3.93 | Why? |
| Sex Workers | 11 | 2020 | 348 | 1.85 | Why? |
| HIV Infections | 30 | 2021 | 11620 | 1.27 | Why? |
| Sexual Partners | 6 | 2018 | 612 | 1.07 | Why? |
| Drug Users | 3 | 2018 | 234 | 0.81 | Why? |
| Risk-Taking | 8 | 2018 | 508 | 0.73 | Why? |
| Family Nursing | 1 | 2018 | 14 | 0.73 | Why? |
| Mexico | 16 | 2018 | 2787 | 0.65 | Why? |
| Violence | 3 | 2017 | 534 | 0.64 | Why? |
| Drug Resistance, Microbial | 1 | 2020 | 419 | 0.62 | Why? |
| Pre-Exposure Prophylaxis | 4 | 2020 | 1138 | 0.56 | Why? |
| Methamphetamine | 5 | 2018 | 82 | 0.55 | Why? |
| Homosexuality, Male | 6 | 2020 | 1158 | 0.54 | Why? |
| Needle Sharing | 2 | 2018 | 23 | 0.50 | Why? |
| Intimate Partner Violence | 1 | 2018 | 363 | 0.48 | Why? |
| Condoms | 3 | 2018 | 235 | 0.48 | Why? |
| Behavior Therapy | 2 | 2017 | 235 | 0.47 | Why? |
| HIV Seropositivity | 2 | 2018 | 320 | 0.46 | Why? |
| Temperance | 1 | 2010 | 2 | 0.45 | Why? |
| Police | 3 | 2018 | 243 | 0.45 | Why? |
| Health Policy | 5 | 2021 | 6242 | 0.44 | Why? |
| HIV Seronegativity | 2 | 2018 | 112 | 0.41 | Why? |
| Unsafe Sex | 3 | 2020 | 139 | 0.39 | Why? |
| Public Health Administration | 1 | 2018 | 846 | 0.38 | Why? |
| Sexual Behavior | 8 | 2018 | 1322 | 0.36 | Why? |
| Substance-Related Disorders | 7 | 2018 | 2038 | 0.35 | Why? |
| Sex Work | 3 | 2018 | 96 | 0.34 | Why? |
| Anti-HIV Agents | 3 | 2018 | 2209 | 0.34 | Why? |
| Marijuana Smoking | 1 | 2008 | 80 | 0.33 | Why? |
| Politics | 1 | 2020 | 1824 | 0.33 | Why? |
| Population Dynamics | 1 | 2009 | 378 | 0.30 | Why? |
| Amphetamine-Related Disorders | 2 | 2017 | 31 | 0.27 | Why? |
| Transgender Persons | 3 | 2018 | 322 | 0.26 | Why? |
| Harm Reduction | 3 | 2018 | 392 | 0.26 | Why? |
| Forecasting | 1 | 2018 | 4492 | 0.25 | Why? |
| Withholding Treatment | 1 | 2009 | 798 | 0.25 | Why? |
| Semen | 1 | 2008 | 550 | 0.25 | Why? |
| HIV-1 | 1 | 2018 | 3365 | 0.24 | Why? |
| Antitubercular Agents | 1 | 2009 | 775 | 0.24 | Why? |
| Emigrants and Immigrants | 2 | 2009 | 888 | 0.24 | Why? |
| Public Health | 7 | 2021 | 16359 | 0.23 | Why? |
| Hepatitis C, Chronic | 1 | 2010 | 973 | 0.22 | Why? |
| Legislation, Drug | 2 | 2018 | 101 | 0.21 | Why? |
| Human Rights | 3 | 2018 | 618 | 0.21 | Why? |
| Vaginal Douching | 1 | 2018 | 6 | 0.19 | Why? |
| Lubrication | 1 | 2018 | 6 | 0.19 | Why? |
| Sexual and Gender Minorities | 2 | 2020 | 1019 | 0.19 | Why? |
| Alcohol Drinking | 1 | 2010 | 1663 | 0.18 | Why? |
| pol Gene Products, Human Immunodeficiency Virus | 1 | 2018 | 39 | 0.18 | Why? |
| Syringes | 1 | 2018 | 70 | 0.18 | Why? |
| Heroin | 1 | 2018 | 41 | 0.18 | Why? |
| Pancreatic Pseudocyst | 1 | 2017 | 23 | 0.18 | Why? |
| Sexuality | 1 | 2018 | 85 | 0.18 | Why? |
| Transsexualism | 1 | 2017 | 43 | 0.18 | Why? |
| Helping Behavior | 1 | 2017 | 30 | 0.17 | Why? |
| Pancreatitis, Acute Necrotizing | 1 | 2017 | 47 | 0.17 | Why? |
| Criminal Law | 1 | 2018 | 84 | 0.17 | Why? |
| Cocaine | 1 | 2018 | 73 | 0.17 | Why? |
| Heterosexuality | 1 | 2018 | 148 | 0.17 | Why? |
| Marijuana Abuse | 1 | 2018 | 111 | 0.17 | Why? |
| Phage Therapy | 1 | 2017 | 63 | 0.17 | Why? |
| Strategic Planning | 1 | 2018 | 122 | 0.16 | Why? |
| Security Measures | 1 | 2019 | 211 | 0.16 | Why? |
| Age of Onset | 1 | 2018 | 557 | 0.15 | Why? |
| Crime Victims | 1 | 2018 | 148 | 0.15 | Why? |
| Vulnerable Populations | 2 | 2021 | 3099 | 0.15 | Why? |
| Law Enforcement | 1 | 2017 | 113 | 0.15 | Why? |
| Prevalence | 7 | 2018 | 25773 | 0.15 | Why? |
| Addiction Medicine | 1 | 2015 | 42 | 0.15 | Why? |
| Social Stigma | 3 | 2020 | 1049 | 0.14 | Why? |
| Philippines | 1 | 2017 | 568 | 0.14 | Why? |
| Epidemics | 3 | 2021 | 6407 | 0.14 | Why? |
| Bacteriophages | 1 | 2017 | 268 | 0.14 | Why? |
| Cannabis | 1 | 2018 | 284 | 0.14 | Why? |
| Smoking | 1 | 2008 | 3358 | 0.14 | Why? |
| Global Burden of Disease | 1 | 2018 | 531 | 0.14 | Why? |
| Acinetobacter Infections | 1 | 2017 | 273 | 0.14 | Why? |
| Adult | 31 | 2021 | 244371 | 0.13 | Why? |
| Acinetobacter baumannii | 1 | 2017 | 378 | 0.13 | Why? |
| Interpersonal Relations | 2 | 2018 | 926 | 0.13 | Why? |
| Humans | 49 | 2021 | 930598 | 0.13 | Why? |
| Cooperative Behavior | 2 | 2019 | 1216 | 0.13 | Why? |
| Male | 33 | 2020 | 367725 | 0.13 | Why? |
| Sexually Transmitted Diseases | 2 | 2020 | 694 | 0.13 | Why? |
| Tuberculosis | 1 | 2009 | 2895 | 0.12 | Why? |
| Affect | 1 | 2018 | 549 | 0.12 | Why? |
| Antiretroviral Therapy, Highly Active | 1 | 2018 | 952 | 0.12 | Why? |
| Peer Group | 1 | 2017 | 402 | 0.12 | Why? |
| Minority Groups | 2 | 2021 | 1631 | 0.12 | Why? |
| Psychotropic Drugs | 1 | 2017 | 396 | 0.12 | Why? |
| Female | 32 | 2020 | 380317 | 0.12 | Why? |
| Opiate Substitution Treatment | 1 | 2018 | 613 | 0.12 | Why? |
| Cities | 3 | 2021 | 4937 | 0.11 | Why? |
| United States | 7 | 2021 | 46150 | 0.11 | Why? |
| Health Knowledge, Attitudes, Practice | 2 | 2017 | 8811 | 0.11 | Why? |
| Population Surveillance | 1 | 2008 | 4967 | 0.11 | Why? |
| Suicide, Attempted | 1 | 2017 | 599 | 0.11 | Why? |
| Socioeconomic Factors | 2 | 2018 | 8495 | 0.10 | Why? |
| Hepatitis C Antibodies | 1 | 2010 | 120 | 0.10 | Why? |
| Anecdotes as Topic | 1 | 2008 | 4 | 0.10 | Why? |
| Health Care Reform | 1 | 2015 | 409 | 0.10 | Why? |
| Viral Load | 4 | 2020 | 15850 | 0.10 | Why? |
| Teaching | 1 | 2018 | 1208 | 0.10 | Why? |
| Social Determinants of Health | 1 | 2021 | 1757 | 0.09 | Why? |
| Markov Chains | 1 | 2010 | 502 | 0.09 | Why? |
| Molecular Epidemiology | 1 | 2014 | 1638 | 0.09 | Why? |
| Policy Making | 1 | 2015 | 829 | 0.09 | Why? |
| Patient Education as Topic | 1 | 2018 | 1476 | 0.09 | Why? |
| Logistic Models | 4 | 2017 | 9089 | 0.09 | Why? |
| Injections | 2 | 2020 | 237 | 0.09 | Why? |
| Prospective Studies | 6 | 2019 | 43301 | 0.09 | Why? |
| HIV | 3 | 2021 | 1116 | 0.09 | Why? |
| Cohort Studies | 8 | 2019 | 36005 | 0.09 | Why? |
| Epidemiological Monitoring | 1 | 2021 | 3493 | 0.09 | Why? |
| Needle-Exchange Programs | 1 | 2008 | 146 | 0.09 | Why? |
| Risk Factors | 7 | 2020 | 71621 | 0.08 | Why? |
| Central Nervous System Stimulants | 1 | 2008 | 111 | 0.08 | Why? |
| Health Equity | 1 | 2018 | 1223 | 0.08 | Why? |
| Asia | 1 | 2013 | 2399 | 0.08 | Why? |
| Suicide | 1 | 2019 | 1500 | 0.08 | Why? |
| Global Health | 4 | 2019 | 13911 | 0.07 | Why? |
| Opioid-Related Disorders | 1 | 2017 | 1185 | 0.07 | Why? |
| International Cooperation | 1 | 2019 | 3436 | 0.07 | Why? |
| Pandemics | 4 | 2021 | 389249 | 0.07 | Why? |
| Alanine Transaminase | 1 | 2010 | 1329 | 0.07 | Why? |
| Liver Function Tests | 1 | 2010 | 1325 | 0.07 | Why? |
| Homeless Persons | 2 | 2020 | 1171 | 0.07 | Why? |
| Aspartate Aminotransferases | 1 | 2010 | 1394 | 0.06 | Why? |
| Adolescent | 10 | 2018 | 86841 | 0.06 | Why? |
| Viremia | 1 | 2010 | 1020 | 0.06 | Why? |
| Multivariate Analysis | 3 | 2017 | 5440 | 0.06 | Why? |
| CD4 Lymphocyte Count | 2 | 2018 | 1517 | 0.06 | Why? |
| Young Adult | 11 | 2018 | 93724 | 0.06 | Why? |
| Bangladesh | 1 | 2008 | 1620 | 0.06 | Why? |
| Social Support | 1 | 2017 | 3183 | 0.06 | Why? |
| Developing Countries | 1 | 2018 | 4283 | 0.06 | Why? |
| Drug Overdose | 2 | 2020 | 583 | 0.06 | Why? |
| Longitudinal Studies | 4 | 2018 | 9893 | 0.06 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.06 | Why? |
| Health Services Accessibility | 2 | 2015 | 10697 | 0.05 | Why? |
| Attitude to Health | 2 | 2018 | 2002 | 0.05 | Why? |
| Proportional Hazards Models | 3 | 2018 | 6543 | 0.05 | Why? |
| Canada | 2 | 2017 | 6018 | 0.05 | Why? |
| Mass Screening | 1 | 2021 | 8005 | 0.05 | Why? |
| Hepatitis C | 1 | 2010 | 1514 | 0.05 | Why? |
| Ukraine | 1 | 2018 | 137 | 0.05 | Why? |
| Middle Aged | 10 | 2018 | 270681 | 0.04 | Why? |
| Contact Tracing | 1 | 2018 | 8448 | 0.04 | Why? |
| Cross-Sectional Studies | 5 | 2017 | 53120 | 0.04 | Why? |
| Adult Survivors of Child Abuse | 1 | 2017 | 34 | 0.04 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.04 | Why? |
| Incidence | 5 | 2018 | 25622 | 0.04 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.04 | Why? |
| Health Surveys | 1 | 2008 | 2841 | 0.04 | Why? |
| Gallstones | 1 | 2017 | 64 | 0.04 | Why? |
| Minocycline | 1 | 2017 | 101 | 0.04 | Why? |
| Surveys and Questionnaires | 5 | 2018 | 43792 | 0.04 | Why? |
| Odds Ratio | 2 | 2018 | 5861 | 0.04 | Why? |
| Philadelphia | 1 | 2017 | 454 | 0.04 | Why? |
| Methadone | 1 | 2018 | 296 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2017 | 10083 | 0.04 | Why? |
| British Columbia | 1 | 2017 | 512 | 0.04 | Why? |
| Kenya | 1 | 2018 | 887 | 0.04 | Why? |
| Prejudice | 1 | 2018 | 245 | 0.04 | Why? |
| Indonesia | 1 | 2018 | 1022 | 0.03 | Why? |
| Depression | 1 | 2018 | 14116 | 0.03 | Why? |
| Spouse Abuse | 1 | 2014 | 55 | 0.03 | Why? |
| Self Concept | 1 | 2018 | 490 | 0.03 | Why? |
| Vietnam | 1 | 2018 | 1665 | 0.03 | Why? |
| Counseling | 1 | 2018 | 747 | 0.03 | Why? |
| Morals | 1 | 2017 | 483 | 0.03 | Why? |
| Prisoners | 1 | 2020 | 738 | 0.03 | Why? |
| Community Participation | 1 | 2018 | 605 | 0.03 | Why? |
| Cost-Benefit Analysis | 1 | 2021 | 2259 | 0.03 | Why? |
| Sex Factors | 2 | 2018 | 11014 | 0.03 | Why? |
| Income | 1 | 2020 | 1564 | 0.03 | Why? |
| Educational Measurement | 1 | 2018 | 930 | 0.03 | Why? |
| California | 1 | 2017 | 2047 | 0.03 | Why? |
| Immunoblotting | 1 | 2010 | 180 | 0.03 | Why? |
| Afghanistan | 1 | 2010 | 224 | 0.03 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2017 | 1115 | 0.02 | Why? |
| Pentanols | 1 | 2008 | 1 | 0.02 | Why? |
| Feasibility Studies | 1 | 2018 | 3467 | 0.02 | Why? |
| South Africa | 1 | 2018 | 3326 | 0.02 | Why? |
| Sulfones | 1 | 2008 | 66 | 0.02 | Why? |
| Sildenafil Citrate | 1 | 2008 | 66 | 0.02 | Why? |
| Nitrates | 1 | 2008 | 98 | 0.02 | Why? |
| Delivery of Health Care | 1 | 2014 | 15909 | 0.02 | Why? |
| Disease Transmission, Infectious | 1 | 2010 | 9044 | 0.02 | Why? |
| Alcohol-Related Disorders | 1 | 2008 | 84 | 0.02 | Why? |
| Mothers | 1 | 2017 | 1624 | 0.02 | Why? |
| Interviews as Topic | 1 | 2015 | 1952 | 0.02 | Why? |
| Self Report | 1 | 2017 | 3802 | 0.02 | Why? |
| Biomarkers | 1 | 2008 | 23361 | 0.02 | Why? |
| Risk | 1 | 2017 | 5288 | 0.02 | Why? |
| Piperazines | 1 | 2008 | 445 | 0.02 | Why? |
| Vasodilator Agents | 1 | 2008 | 344 | 0.02 | Why? |
| Research | 1 | 2017 | 2115 | 0.02 | Why? |
| Qualitative Research | 1 | 2015 | 4337 | 0.02 | Why? |
| Neuropsychological Tests | 1 | 2008 | 954 | 0.01 | Why? |
| Purines | 1 | 2008 | 816 | 0.01 | Why? |
| Occupational Health | 1 | 2017 | 3965 | 0.01 | Why? |
| Treatment Outcome | 2 | 2018 | 51732 | 0.01 | Why? |
| Models, Theoretical | 1 | 2018 | 6659 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2017 | 17020 | 0.01 | Why? |
| Aged | 3 | 2019 | 215776 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.01 | Why? |
| Mental Health | 1 | 2017 | 15770 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 13720 | 0.01 | Why? |
| Stress, Psychological | 1 | 2014 | 10231 | 0.01 | Why? |
Strathdee's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(210)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(45)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_